ERIN THORNTON: Open Payments
NPI 1598869992 · MANHATTAN, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,393 in 125 payments from 18 companies in 2025. Trend: 2023 $1,063 · 2024 $2,664 · 2025 $2,393
Food & beverage: $2,208Education: $185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $489 |
| Janssen Biotech, Inc. | 20 | $443 |
| E.R. Squibb & Sons, L.L.C. | 20 | $264 |
| Novartis Pharmaceuticals Corporation | 12 | $259 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $212 |
| Amgen Inc. | 10 | $139 |
| GENZYME CORPORATION | 3 | $92 |
| Kerecis Limited | 6 | $90 |
| Regeneron Healthcare Solutions, Inc. | 3 | $81 |
| UCB, Inc. | 3 | $63 |
Products named: TREMFYA, RINVOQ, Sotyktu, COSENTYX, DUPIXENT, SKYRIZI, OTEZLA, Kerecis SurgiClose.
Industry payments across KS — which companies pay providers there.
